-
1
المؤلفون: Mojca, Jensterle, Manfredi, Rizzo, Martin, Haluzík, Andrej, Janež
المساهمون: Jensterle, Mojca, Rizzo, Manfredi, Haluzík, Martin, Janež, Andrej
مصطلحات موضوعية: Diabetes Mellitus, Type 2, Glucagon-Like Peptide 1, Weight Loss, Glucagon-Like Peptides, Diabetes, GLP-1 RAs, Liraglutide, Obesity, Semaglutide, Humans, Hypoglycemic Agents, Pharmacology (medical), Obesity, General Medicine, Liraglutide, Weight Gain, Glucagon-Like Peptide-1 Receptor
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2cd738c2e382889801d3387b0191cf0Test
https://hdl.handle.net/10447/584531Test -
2
المؤلفون: Deborah J. Wexler, Chantal Mathieu, Peter Rossing, Judith E. Fradkin, Geltrude Mingrone, Apostolos Tsapas, David A. D'Alessio, Walter N. Kernan, John B. Buse, Melanie J. Davies
المصدر: Diabetes Care
مصطلحات موضوعية: 0301 basic medicine, Glucose-lowering therapy, Endocrinology, Diabetes and Metabolism, Disease, Type 2 diabetes, 030204 cardiovascular system & hematology, chemistry.chemical_compound, 0302 clinical medicine, Chronic kidney disease, Weight management, CARDIOVASCULAR RISK-FACTORS, Insulin, MULTIPLE DAILY INJECTIONS, RANDOMIZED CONTROLLED-TRIAL, Cardiovascular disease, Lifestyle management, 3. Good health, Europe, Cardiovascular Diseases, CLINICAL-PRACTICE GUIDELINES, Life Sciences & Biomedicine, Type 2, Adult, medicine.medical_specialty, Consensus, Consensus Report, 030209 endocrinology & metabolism, Heart failure, Patient-centred care, Guidelines, Glucagon-Like Peptide-1 Receptor, 03 medical and health sciences, Lixisenatide, Endocrinology & Metabolism, Internal medicine, Diabetes mellitus, Weight Loss, Type 2 diabetes mellitus, Diabetes Mellitus, Internal Medicine, medicine, Humans, Hypoglycemic Agents, Obesity, COTRANSPORTER 2 INHIBITORS, Renal Insufficiency, Chronic, Intensive care medicine, Life Style, Sodium-Glucose Transporter 2 Inhibitors, INTENSIVE MEDICAL THERAPY, Advanced and Specialized Nursing, Science & Technology, business.industry, Semaglutide, Settore MED/09 - MEDICINA INTERNA, Type 2 Diabetes Mellitus, Liraglutide, medicine.disease, United States, Costs, GLARGINE PLUS LIXISENATIDE, FIXED-RATIO COMBINATION, 030104 developmental biology, chemistry, Diabetes Mellitus, Type 2, Hyperglycemia, PEPTIDE-1 RECEPTOR AGONISTS, business, Hypoglycaemia, Mace, Kidney disease, DIPEPTIDYL PEPTIDASE-4 INHIBITORS
وصف الملف: Print
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a5e07d878a99a4bdc6a4d6c6f273125Test
https://lirias.kuleuven.be/handle/123456789/633989Test